Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.

Sinnaeve PR, Schwartz GG, Wojdyla DM, Alings M, Bhatt DL, Bittner VA, Chiang CE, Correa Flores RM, Diaz R, Dorobantu M, Goodman SG, Jukema JW, Kim YU, Pordy R, Roe MT, Sy RG, Szarek M, White HD, Zeiher AM, Steg PG; ODYSSEY OUTCOMES Investigators.

Eur Heart J. 2019 Nov 16. pii: ehz809. doi: 10.1093/eurheartj/ehz809. [Epub ahead of print]

PMID:
31732742
2.

Stent Thrombosis in Patients with Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.

Lopes RD, Leonardi S, Wojdyla DM, Vora AN, Thomas L, Storey RF, Vinereanu D, Granger CB, Goodman SG, Aronson R, Windecker S, Thiele H, Valgimigli M, Mehran R, Alexander JH.

Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044584. [Epub ahead of print]

PMID:
31707833
3.

The Accuracy of Cardiovascular Pooled Cohort Risk Estimates in U.S. Older Adults.

Nanna MG, Peterson ED, Wojdyla D, Navar AM.

J Gen Intern Med. 2019 Oct 30. doi: 10.1007/s11606-019-05361-4. [Epub ahead of print]

PMID:
31667745
4.

Differential Treatments Based on Drug-induced Gene Expression Signatures and Longitudinal Systemic Lupus Erythematosus Stratification.

Toro-Domínguez D, Lopez-Domínguez R, García Moreno A, Villatoro-García JA, Martorell-Marugán J, Goldman D, Petri M, Wojdyla D, Pons-Estel BA, Isenberg D, Morales-Montes de Oca G, Trejo-Zambrano MI, García González B, Rosetti F, Gómez-Martín D, Romero-Díaz J, Carmona-Sáez P, Alarcón-Riquelme ME.

Sci Rep. 2019 Oct 29;9(1):15502. doi: 10.1038/s41598-019-51616-9.

5.

Impact of curcumin on replicative and chronological aging in the Saccharomyces cerevisiae yeast.

Stępień K, Wojdyła D, Nowak K, Mołoń M.

Biogerontology. 2019 Oct 28. doi: 10.1007/s10522-019-09846-x. [Epub ahead of print]

PMID:
31659616
6.

Hospitalization among Patients with Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated with Apixaban or Aspirin: Insights from the AUGUSTUS Trial.

Vora AN, Alexander JH, Wojdyla D, Aronson R, Granger CB, Darius H, Windecker S, Mehran R, Averkov O, Budaj AJ, Kong DF, Kobalava Z, Mehta RH, Mirza Z, Guimaraes PO, Parkhomenko A, Quadros A, Thiele H, Goodman SG, Lopes RD.

Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.043754. [Epub ahead of print]

PMID:
31553201
7.

Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.

Åkerblom A, Wojdyla D, Steg PG, Wallentin L, James SK, Budaj A, Katus HA, Himmelmann A, Huber K, Siegbahn A, Storey RF, Becker RC; PLATO Investigators.

J Thromb Thrombolysis. 2019 Nov;48(4):563-569. doi: 10.1007/s11239-019-01938-2.

8.

Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial).

Goldstein SA, Green J, Huber K, Wojdyla DM, Lopes RD, Alexander JH, Vinereanu D, Wallentin L, Granger CB, Al-Khatib SM.

Am J Cardiol. 2019 Nov 1;124(9):1406-1412. doi: 10.1016/j.amjcard.2019.07.046. Epub 2019 Aug 7.

PMID:
31474328
9.

Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.

Edmonston D, Wojdyla D, Mehta R, Cai X, Lora C, Cohen D, Townsend RR, He J, Go AS, Kusek J, Weir MR, Isakova T, Pencina M, Wolf M; CRIC Study Investigators.

Am J Kidney Dis. 2019 Aug 21. pii: S0272-6386(19)30848-0. doi: 10.1053/j.ajkd.2019.05.026. [Epub ahead of print]

PMID:
31445926
10.

Novel application of approaches to predicting medication adherence using medical claims data.

Zullig LL, Jazowski SA, Wang TY, Hellkamp A, Wojdyla D, Thomas L, Egbuonu-Davis L, Beal A, Bosworth HB.

Health Serv Res. 2019 Aug 20. doi: 10.1111/1475-6773.13200. [Epub ahead of print]

PMID:
31429471
11.
12.

Ad hoc percutaneous coronary intervention in patients with stable coronary artery disease: A report from the National Cardiovascular Data Registry CathPCI Registry.

Faridi KF, Rymer JA, Rao SV, Dai D, Wojdyla D, Yeh RW, Wang TY.

Am Heart J. 2019 Oct;216:53-61. doi: 10.1016/j.ahj.2019.07.004. Epub 2019 Jul 13.

PMID:
31401443
13.

Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial.

Sharma A, Hagström E, Wojdyla DM, Neely ML, Harrington RA, Wallentin L, Alexander JH, Goodman SG, Lopes RD; Apixaban for Prevention of Acute Ischemic Safety Events APPRAISE-2 Steering Committee and Investigators.

Am Heart J. 2019 Sep;215:106-113. doi: 10.1016/j.ahj.2019.05.004. Epub 2019 May 11.

PMID:
31310855
14.

Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.

Pimentel-Quiroz VR, Ugarte-Gil MF, Harvey GB, Wojdyla D, Pons-Estel GJ, Quintana R, Esposto A, García MA, Catoggio LJ, Cardiel MH, Barile LA, Amigo MC, Sato EI, Bonfa E, Borba E, Lavras Costallat LT, Neira OJ, Massardo L, Guibert-Toledano M, Chacón-Díaz R, Alarcón GS, Pons-Estel BA.

Lupus. 2019 Aug;28(9):1101-1110. doi: 10.1177/0961203319860579. Epub 2019 Jul 10.

PMID:
31291843
15.

Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.

Åkerblom A, Wojdyla DM, Wallentin L, James SK, de Souza Brito F, Steg PG, Cannon CP, Katus HA, Himmelmann A, Storey RF, Becker RC, Lopes RD; PLATO Investigators.

Am Heart J. 2019 Jul;213:57-65. doi: 10.1016/j.ahj.2019.04.006. Epub 2019 Apr 18.

PMID:
31108273
16.

Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women.

Rymer JA, Kaltenbach LA, Kochar A, Hess CN, Gilchrist IC, Messenger JC, Harrington RA, Jolly SS, Jacobs AK, Abbott JD, Wojdyla DM, Krucoff MW, Rao SV.

Circ Cardiovasc Interv. 2019 May;12(5):e007086. doi: 10.1161/CIRCINTERVENTIONS.118.007086.

PMID:
31014090
17.

Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial.

Guimarães PO, Pokorney SD, Lopes RD, Wojdyla DM, Gersh BJ, Giczewska A, Carnicelli A, Lewis BS, Hanna M, Wallentin L, Vinereanu D, Alexander JH, Granger CB.

Clin Cardiol. 2019 May;42(5):568-571. doi: 10.1002/clc.23178. Epub 2019 Apr 9.

18.

Evaluation of Mortality Data From the Social Security Administration Death Master File for Clinical Research.

Navar AM, Peterson ED, Steen DL, Wojdyla DM, Sanchez RJ, Khan I, Song X, Gold ME, Pencina MJ.

JAMA Cardiol. 2019 Apr 1;4(4):375-379. doi: 10.1001/jamacardio.2019.0198.

19.

Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Quintana R, Gómez-Puerta JA, Catoggio LJ, Alvarellos A, Saurit V, Borba E, Sato E, Costallat L, Da Silva NA, Iglesias-Gamarra A, Neira O, Reyes-Llerena G, Cardiel MH, Amigo MC, Acevedo-Vásquez E, Esteva-Spinetti MH, Alarcón GS, Pons-Estel BA.

J Rheumatol. 2019 Oct;46(10):1299-1308. doi: 10.3899/jrheum.180433. Epub 2019 Mar 1.

PMID:
30824636
20.

Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial.

Washam JB, Hohnloser SH, Lopes RD, Wojdyla DM, Vinereanu D, Alexander JH, Gersh BJ, Hanna M, Horowitz J, Hylek EM, Xavier D, Verheugt FWA, Wallentin L, Granger CB; ARISTOTLE Committees and Investigators.

J Thromb Thrombolysis. 2019 Apr;47(3):345-352. doi: 10.1007/s11239-019-01823-y.

PMID:
30790160
21.

Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight.

Hohnloser SH, Fudim M, Alexander JH, Wojdyla DM, Ezekowitz JA, Hanna M, Atar D, Hijazi Z, Bahit MC, Al-Khatib SM, Lopez-Sendon JL, Wallentin L, Granger CB, Lopes RD.

Circulation. 2019 May 14;139(20):2292-2300. doi: 10.1161/CIRCULATIONAHA.118.037955.

PMID:
30773022
22.

Relationship Between Optimism and Outcomes in Patients With Chronic Angina Pectoris.

Fanaroff AC, Prather K, Brucker A, Wojdyla D, Davidson-Ray L, Mark DB, Williams RB, Barefoot J, Weisz G, Ben-Yehuda O, Stone GW, Ohman EM, Alexander KP.

Am J Cardiol. 2019 May 1;123(9):1399-1405. doi: 10.1016/j.amjcard.2019.01.036. Epub 2019 Feb 7.

PMID:
30771861
23.

Estimating Clinical Trial Bleeding Events Using Electronic Health Record Data.

Eisenstein EL, Wojdyla D, Kong DF.

Stud Health Technol Inform. 2019;257:92-97.

PMID:
30741179
24.

Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry.

Secemsky EA, Ferro EG, Rao SV, Kirtane A, Tamez H, Zakroysky P, Wojdyla D, Bradley SM, Cohen DJ, Yeh RW.

JAMA Cardiol. 2019 Feb 1;4(2):110-118. doi: 10.1001/jamacardio.2018.4472.

PMID:
30624549
25.

Quantifying Importance of Major Risk Factors for Coronary Heart Disease.

Pencina MJ, Navar AM, Wojdyla D, Sanchez RJ, Khan I, Elassal J, D'Agostino RB Sr, Peterson ED, Sniderman AD.

Circulation. 2019 Mar 26;139(13):1603-1611. doi: 10.1161/CIRCULATIONAHA.117.031855.

26.

Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention.

Fanaroff AC, Zakroysky P, Wojdyla D, Kaltenbach LA, Sherwood MW, Roe MT, Wang TY, Peterson ED, Gurm HS, Cohen MG, Messenger JC, Rao SV.

Circulation. 2019 Jan 22;139(4):458-472. doi: 10.1161/CIRCULATIONAHA.117.033325.

PMID:
30586696
27.

Comparison of Outcomes and Frequency of Graft Failure With Use of Free Versus In Situ Internal Mammary Artery Bypass Conduits (from the PREVENT IV Trial).

Ranney DN, Williams JB, Mulder H, Wojdyla D, Cox ML, Gibson CM, Mack MJ, Daneshmand MA, Alexander JH, Lopes RD.

Am J Cardiol. 2019 Feb 15;123(4):571-575. doi: 10.1016/j.amjcard.2018.11.029. Epub 2018 Nov 24.

PMID:
30538035
28.

Distribution of postpartum blood loss: modeling, estimation and application to clinical trials.

Carvalho JF, Piaggio G, Wojdyla D, Widmer M, Gülmezoglu AM.

Reprod Health. 2018 Dec 4;15(1):199. doi: 10.1186/s12978-018-0641-1.

29.

Is Low Disease Activity Sufficient as a Target in Systemic Lupus Erythematosus? Comment on the Article by Petri et al.

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Pons-Estel BA, Alarcón GS.

Arthritis Rheumatol. 2018 Dec;70(12):2098-2099. doi: 10.1002/art.40694. Epub 2018 Sep 24. No abstract available.

PMID:
30120903
30.

Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome.

Inohara T, Pieper K, Wojdyla DM, Patel MR, Jones WS, Tricoci P, Mahaffey KW, James SK, Alexander JH, Lopes RD, Wallentin L, Ohman EM, Roe MT, Vemulapalli S.

Am Heart J. 2018 Jul;201:25-32. doi: 10.1016/j.ahj.2018.03.013. Epub 2018 Mar 28.

PMID:
29910052
31.

Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery.

Wang A, Wu A, Wojdyla D, Lopes RD, Newby LK, Newman MF, Smith PK, Alexander JH.

Am Heart J. 2018 May;199:150-155. doi: 10.1016/j.ahj.2018.02.006. Epub 2018 Feb 11.

PMID:
29754654
32.

Digoxin and Mortality in Patients With Atrial Fibrillation.

Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, Ridefelt P, Lawrence JH, De Caterina R, Vinereanu D, Hanna M, Flaker G, Al-Khatib SM, Hohnloser SH, Alexander JH, Granger CB, Wallentin L; ARISTOTLE Committees and Investigators.

J Am Coll Cardiol. 2018 Mar 13;71(10):1063-1074. doi: 10.1016/j.jacc.2017.12.060.

33.

Appropriateness and Outcomes of Percutaneous Coronary Intervention at Top-Ranked and Nonranked Hospitals in the United States.

Sukul D, Bhatt DL, Seth M, Zakroysky P, Wojdyla D, Rumsfeld JS, Wang T, Rao SV, Gurm HS.

JACC Cardiovasc Interv. 2018 Feb 26;11(4):342-350. doi: 10.1016/j.jcin.2017.10.042. Epub 2017 Nov 12.

34.

Blood Pressure Response during Cardiopulmonary Exercise Testing in Heart Failure.

Il'giovine ZJ, Solomon N, Devore AD, Wojdyla D, Patel CB, Rogers JG.

Med Sci Sports Exerc. 2018 Jul;50(7):1345-1349. doi: 10.1249/MSS.0000000000001587.

PMID:
29470280
35.

Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial.

Kopin D, Jones WS, Sherwood MW, Wojdyla DM, Wallentin L, Lewis BS, Verheugt FWA, Vinereanu D, Bahit MC, Halvorsen S, Huber K, Parkhomenko A, Granger CB, Lopes RD, Alexander JH.

Am Heart J. 2018 Mar;197:133-141. doi: 10.1016/j.ahj.2017.11.005. Epub 2017 Nov 10.

PMID:
29447773
36.

Anticoagulant Use Among Patients With End-Stage Renal Disease Undergoing Percutaneous Coronary Intervention: An Analysis From the National Cardiovascular Data Registry.

Washam JB, Kaltenbach LA, Wojdyla DM, Patel MR, Klein AJ, Abbott JD, Rao SV.

Circ Cardiovasc Interv. 2018 Feb;11(2):e005628. doi: 10.1161/CIRCINTERVENTIONS.117.005628.

PMID:
29432119
37.

Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE.

Goto S, Merrill P, Wallentin L, Wojdyla DM, Hanna M, Avezum A, Easton JD, Harjola VP, Huber K, Lewis BS, Parkhomenko A, Zhu J, Granger CB, Lopes RD, Alexander JH.

Eur Heart J Cardiovasc Pharmacother. 2018 Apr 1;4(2):75-81. doi: 10.1093/ehjcvp/pvy002.

PMID:
29385429
38.

Remission or low disease activity as a target in systemic lupus erythematosus.

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Pons-Estel BA, Alarcón GS; GLADEL.

Ann Rheum Dis. 2019 Jan;78(1):e3. doi: 10.1136/annrheumdis-2017-212876. Epub 2018 Jan 8. No abstract available.

PMID:
29311147
39.

Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial.

Norgren L, Patel MR, Hiatt WR, Wojdyla DM, Fowkes FGR, Baumgartner I, Mahaffey KW, Berger JS, Jones WS, Katona BG, Held P, Blomster JI, Rockhold FW, Björck M; EUCLID Steering Committee and Investigators.

Eur J Vasc Endovasc Surg. 2018 Jan;55(1):109-117. doi: 10.1016/j.ejvs.2017.11.006. Epub 2017 Dec 20.

40.

Lower Repeat Revascularization Rates Among Patients With Prior Coronary Artery Bypass Graft Surgery are Due to Lack of Adequate Target Vessels.

Kumar A, Wagener JF, Wojdyla D, Jones WS, Patel MR, Rao SV.

J Invasive Cardiol. 2018 Feb;30(2):51-55. Epub 2017 Nov 15.

41.

Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial.

Rao MP, Vinereanu D, Wojdyla DM, Alexander JH, Atar D, Hylek EM, Hanna M, Wallentin L, Lopes RD, Gersh BJ, Granger CB; Apixaban for Reduction in Stroke Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Investigators.

Am J Med. 2018 Mar;131(3):269-275.e2. doi: 10.1016/j.amjmed.2017.10.036. Epub 2017 Nov 6.

PMID:
29122636
42.

Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Catoggio LJ, Drenkard C, Sarano J, Berbotto GA, Borba EF, Sato EI, Tavares Brenol JC, Uribe O, Ramirez Gómez LA, Guibert-Toledano M, Massardo L, Cardiel MH, Silveira LH, Chacón-Diaz R, Alarcón GS, Pons-Estel BA; GLADEL.

Ann Rheum Dis. 2017 Dec;76(12):2071-2074. doi: 10.1136/annrheumdis-2017-211814. Epub 2017 Sep 22.

PMID:
28939626
43.

Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.

Ugarte-Gil MF, Wojdyla D, Pastor-Asurza CA, Gamboa-Cárdenas RV, Acevedo-Vásquez EM, Catoggio LJ, García MA, Bonfá E, Sato EI, Massardo L, Pascual-Ramos V, Barile LA, Reyes-Llerena G, Iglesias-Gamarra A, Molina-Restrepo JF, Chacón-Díaz R, Alarcón GS, Pons-Estel BA.

Lupus. 2018 Apr;27(4):536-544. doi: 10.1177/0961203317728810. Epub 2017 Aug 31.

PMID:
28857715
44.

Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States.

Fanaroff AC, Zakroysky P, Dai D, Wojdyla D, Sherwood MW, Roe MT, Wang TY, Peterson ED, Gurm HS, Cohen MG, Messenger JC, Rao SV.

J Am Coll Cardiol. 2017 Jun 20;69(24):2913-2924. doi: 10.1016/j.jacc.2017.04.032.

45.

Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect.

Guimarães PO, Lopes RD, Wojdyla DM, Abdul-Rahim AH, Connolly SJ, Flaker GC, Wang J, Hanna M, Granger CB, Wallentin L, Lees KR, Alexander JH, McMurray JJV.

Cardiovasc Drugs Ther. 2017 Jun;31(3):295-301. doi: 10.1007/s10557-017-6728-z.

PMID:
28516318
46.

Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).

Orgel R, Wojdyla D, Huberman D, Halperin JL, Breithardt G, Singer DE, Fox KAA, Hankey GJ, Mahaffey KW, Jones WS, Patel MR.

Circ Cardiovasc Qual Outcomes. 2017 May;10(5). pii: e003520. doi: 10.1161/CIRCOUTCOMES.116.003520. Review. No abstract available.

47.

Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial.

Ambrosy AP, Cerbin LP, DeVore AD, Greene SJ, Kraus WE, O'Connor CM, Piña IL, Whellan DJ, Wojdyla D, Wu A, Mentz RJ.

Am Heart J. 2017 Apr;186:130-138. doi: 10.1016/j.ahj.2016.12.017. Epub 2017 Jan 19.

PMID:
28454828
48.

An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome.

Pagidipati NJ, Hess CN, Clare RM, Akerblom A, Tricoci P, Wojdyla D, Keenan RT, James S, Held C, Mahaffey KW, Klein AB, Wallentin L, Roe MT.

Am Heart J. 2017 May;187:53-61. doi: 10.1016/j.ahj.2017.02.023. Epub 2017 Feb 21.

PMID:
28454808
49.

Pleuropulmonary involvement in patients with systemic lupus erythematosus from a Latin American inception cohort (GLADEL).

Haye Salinas MJ, Caeiro F, Saurit V, Alvarellos A, Wojdyla D, Scherbarth HR, de O E Silva AC, Tavares Brenol JC, Lavras Costallat LT, Neira OJ, Iglesias Gamarra A, Vásquez G, Reyes Llerena GA, Barile-Fabris LA, Silveira LH, Sauza Del Pozo MJ, Acevedo Vásquez EM, Alfaro Lozano JL, Esteva Spinetti MH, Alarcón GS, Pons-Estel BA; Grupo Latino Americano De Estudio del Lupus (GLADEL).

Lupus. 2017 Nov;26(13):1368-1377. doi: 10.1177/0961203317699284. Epub 2017 Mar 22.

PMID:
28420071
50.

Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy.

Lopes RD, Guimarães PO, Kolls BJ, Wojdyla DM, Bushnell CD, Hanna M, Easton JD, Thomas L, Wallentin L, Al-Khatib SM, Held C, Gabriel Melo de Barros E Silva P, Alexander JH, Granger CB, Diener HC.

Blood. 2017 Jun 1;129(22):2980-2987. doi: 10.1182/blood-2016-08-731638. Epub 2017 Mar 29.

PMID:
28356246

Supplemental Content

Loading ...
Support Center